Hikaru Kuribara

Hikaru Kuribara

Auto-generated profile, based on publicly available information

Hikaru Kuribara

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2025 in Clinical Endoscopy
Verified
Journal Article
Open access
THTakuma Hiramatsu
Takuma Hiramatsu
NKNaomi Kakushima
Naomi Kakushima
HKHikaru Kuribara
Hikaru Kuribara
RMRyohei Miyata
Ryohei Miyata
HNHideki Nakagawa
Hideki Nakagawa
MFMitsuhiro Fujishiro
Mitsuhiro Fujishiro
Approximately 90% of cases of gastric cancer (GC) are caused by Helicobacter pylori infection, and screening esophagogastroduodenoscopy is effective for secondary prevention of GC. Endoscopic findings of the stomach due to H. pylori infection vary widely, and the risk of GC varies according to each finding. GC risk is evaluated by combining endoscopic and histopathological findings. In the operative link on gastritis assessment and operative link on gastric intestinal metaplasia assessment staging, GC risk is determined by histopathological evaluation. In the endoscopic grading of gastric intestinal metaplasia, Kyoto classification, and modified Kyoto classification, the risk is considered based on endoscopic findings. However, evaluating endoscopic findings is challenging because the evaluation varies depending on the skill of the endoscopist. Similarly, histopathological findings can be assessed differently by different pathologists. Histopathological evaluation by biopsy carries a risk of bleeding; thus, simpler and less-invasive risk stratification methods are desirable. Artificial intelligence for risk stratification, which has the potential for improved accuracy and consistency, has been developed for endoscopic and histopathological evaluations. Appropriate GC risk stratification would benefit the economy and patients, and further evaluation of surveillance intervals tailored to individual risks is warranted.

30 July 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
HHHiroyuki Hisada
Hiroyuki Hisada
YTYosuke Tsuji
Yosuke Tsuji
HKHikaru Kuribara
Hikaru Kuribara
RMRyohei Miyata
Ryohei Miyata
KOKaori Oshio
Kaori Oshio
MFMitsuhiro Fujishiro
Mitsuhiro Fujishiro
With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD.